From: Implementation of a comprehensive clinical quality assurance system in radiation oncology
Grade | 0 | 1 | 2 | 3 | 4 | not assessed |
---|---|---|---|---|---|---|
General toxicities eral toxicities | ||||||
Anemia | 19 | 12 | ||||
Dermatitis radiation | 208 | 1 | ||||
Fatigue | 161 | 46 | 2 | |||
Lymphedema | 209 | |||||
Lymphocyte count decreased | 17 | 14 | ||||
Nausea | 209 | |||||
Neutrophil count decreased | 17 | 14 | ||||
Osteonecrosis | 209 | |||||
Pain | 189 | 19 | 1 | |||
Peripheral neuropathy | 209 | |||||
Platelet count decreased | 17 | 14 | ||||
Weight loss | 207 | 1 | 1 | |||
White blood cell count decreased | 17 | 14 | ||||
Genitourinary toxicities nitourinary toxicities | ||||||
Dysuria | 139 | 65 | 5 | |||
Hematuria | 200 | 7 | 1 | 1 | ||
Urinary frequency | 73 | 115 | 21 | |||
Urinary incontinence | 185 | 21 | 2 | 1 | ||
Urinary tract obstruction | 168 | 36 | 4 | 1 | ||
Urinary urgency | 127 | 70 | 11 | 1 | ||
Gastrointestinal toxicities inal toxicities | ||||||
Constipation | 2 | |||||
Diarrhea | 187 | 18 | 4 | |||
Fecal incontinence | 206 | 3 | ||||
Proctitis | 190 | 17 | 2 | |||
Rectal hemorrhage | 209 | |||||
Erectile dysfunction | ||||||
Erectile dysfunction | 159 | 21 | 14 | 11 | 4 |